Versant Venture Management as of Sept. 30, 2023
Portfolio Holdings for Versant Venture Management
Versant Venture Management holds 8 positions in its portfolio as reported in the September 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| RayzeBio Common Stock | 60.9 | $115M | 5.2M | 22.20 | |
| Repare Therapeutics Common Stock (RPTX) | 17.0 | $32M | 2.6M | 12.08 | |
| CRISPR Therapeutics Common Shares (CRSP) | 12.0 | $23M | 499k | 45.39 | |
| Adverum Biotechnologies Common Stock | 4.0 | $7.6M | 5.1M | 1.50 | |
| Gritstone Oncology Common Stock (GRTS) | 3.3 | $6.1M | 3.6M | 1.72 | |
| Passage Bio Common Stock (PASG) | 1.7 | $3.3M | 5.0M | 0.66 | |
| Aligos Therapeutics Common Stock (ALGS) | 0.9 | $1.7M | 2.3M | 0.75 | |
| Minerva Surgical Common Stock | 0.1 | $275k | 84k | 3.29 |
